Touro College Announces Support for CanniCare's Medical Cannabis License Application

AIRMONT, NY – Touro College has announced that it is supporting Rockland County-based CanniCare's application for one of five media marijuana licenses to be issued by the New York State Dept. of Health (DOH).

If CanniCare is selected, Touro would provide the company with research into medicinal cannabis.

"Our college is supportive of medicinal development and research," says Alan H. Kadish, president of the Touro College System. "There is still a great deal of research to be conducted on the medical application of cannabis and we are excited by the opportunity to contribute in a meaningful way. We will also offer CanniCare advice on the clinical use of the medicine along the way."

Some of the research — to be funded from CanniCare profits — will be designed to ensure that the benefits of using medical marijuana are fully understood and that the risks are carefully considered.

"The State of New York is already working on a policy for when and how to prescribe medical cannabis, but there are always post-market refinements based on outcomes and protocols, and that's an element of the research we would conduct," Dr. Kadish says.

CanniCare's manufacturing facility will be near Stewart International Airport in Orange County. The company would operate dispensaries in Manhattan, Rockland County, Schenectady, and Rochester.

CanniCare plans to use a unique standardization technique, to which the company has access through its Canadian partner ABcann Medicinals, a world leader in plant standardization in the phytopharmaceutical industry. The process stems from intellectual properties, methods and licenses from around the world.

Standardization and being able to produce high quality medicine is the key to ensuring quality. The manufacturer must be able to reliably create and reproduce medicine within a very narrow margin of deviation, have medical manufacturing facilities standardization, and have all forms of the medicine carefully tracked and controlled, with all the genetics of one specific type.

"If we are fortunate enough to be chosen by DOH to serve New Yorkers who need this medicine, we have a responsibility to fund ongoing research so that the science and efficacy of medical marijuana continue to advance," says CanniCare CEO Joseph Zupnik. "We are honored that Touro College will be supporting us on public health initiatives in this endeavor."

Featured

  • Spaces4Learning Announces Winners of 2025 Product Awards

    Spaces4Learning has just announced the winners of the 2025 Product Awards! The award program recognizes innovation and excellence in products that enhance learning environments in K–12 schools and institutions of higher education.

  • California Middle School Completes Two New Academic Buildings

    Sunnyvale Middle School in Sunnyvale, Calif., recently announced that construction is complete on two new classroom buildings of two stories each, according to a district news release. The new wing will house seventh- and eighth-grade students and is part of a larger campus modernization project.

  • ClassVR Wins Tech & Learning Best of Show at ISTELive 25

    Avantis Education recently announced that its flagship product, ClassVR, won the Tech & Learning Best of Show Award at ISTELive 25 in San Antonio, Texas, according to a news release. The program is designed to celebrate products that are “transforming education in schools around the world and that show the greatest promise for the industry,” and this is the fourth consecutive year that Avantis has claimed the award.

  • Tennessee State University Gains Approval for New Engineering Facility

    Tennessee State University in Nashville, Tenn., recently announced that it has received approval from the Tennessee State Building Commission to build a new engineering building on campus, according to a university news release. The 70,000-square-foot, $50-million facility will play home to the university’s engineering programs and the Applied & Industrial Technology program.